Therapeutic compounds derived from spider venom and their method of use
US8173797B2 · kind B2 · utility
1Cited by
18References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2005 |
| Grant date | May 8, 2012 |
| Priority date | — |
| Expiry date | Apr 5, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to new therapeutic compounds isolated from spider venom and methods of using these new compounds. The compounds are sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine. Some of these compounds are glycosylated or fucosylated bearing one or more sugar residues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.